Syk/NF-kappa B-targeted anti-inflammatory activity of Melicope accedens (Blume) TG Hartley methanol extract

Abstract

Ethnopharmacological relevance: Melicope accedens (Blume) Thomas G. Hartley is a plant included in the family Rutaceae and genus Melicope. It is a native plant from Vietnam that has been used for ethnopharmacology. In Indonesia and Malaysia, the leaves of M. accedens are applied externally to decrease fever. Aim of the study: The molecular mechanisms of the anti-inflammatory properties of M. accedens are not yet understood. Therefore, we examined those mechanisms using a methanol extract of M. accedens (Ma-ME) and determined the target molecule in macrophages. Materials and methods: We evaluated the anti-inflammatory effects of Ma-ME in lipopolysaccharide (LPS)stimulated RAW264.7 cells and in an HCl/EtOH-triggered gastritis model in mice. To investigate the anti-inflammatory activity, we performed a nitric oxide (NO) production assay and ELISA assay for prostaglandin E2 (PGE 2 ). RT-PCR, luciferase gene reporter assays, western blotting analyses, and a cellular thermal shift assay (CETSA) were conducted to identify the mechanism and target molecule of Ma-ME. The phytochemical composition of Ma-ME was analyzed by HPLC and LC-MS/MS. Results: Ma-ME suppressed the production of NO and PGE(2) and the mRNA expression of proinflammatory genes (iNOS, IL-1 beta, and COX-2) in LPS-stimulated RAW264.7 cells without cytotoxicity. Ma-ME inhibited NF-kappa B activation by suppressing signaling molecules such as I kappa B alpha, Akt, Src, and Syk. Moreover, the CETSA assay revealed that Ma-ME binds to Syk, the most upstream molecule in the NF-kappa B signal pathway. Oral administration of Ma-ME not only alleviated inflammatory lesions, but also reduced the gene expression of IL-1 beta and p-Syk in mice with HCl/EtOH-induced gastritis. HPLC and LC-MS/MS analyses confirmed that Ma-ME contains various anti-inflammatory flavonoids, including quercetin, daidzein, and nevadensin. Conclusions: Ma-ME exhibited anti-inflammatory activities in vitro and in vivo by targeting Syk in the NF-kappa B signaling pathway. Therefore, we propose that Ma-ME could be used to treat inflammatory diseases such as gastritis.